This inventor holds 1 USPTO granted patent. Top assignee: The Ohio State University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Ulyana Munoz Acuna: Innovator in Antimicrobial Research
Introduction
Ulyana Munoz Acuna is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of antimicrobial research, focusing on small molecule antimicrobials. Her innovative work aims to address bacterial infections and improve health outcomes.
Latest Patents
Ulyana holds 1 patent for her invention related to small molecule antimicrobials. The patent describes compounds and compositions of matter that are effective in combating bacterial infections. Specifically, the compounds include JH-144, TH-04, or TH-08, either individually or in combination. The compositions may also incorporate a carrier and, in some cases, a pharmaceutically acceptable excipient, film, biofilm, or edible film. The methods of use outlined in her patent suggest that the composition can be administered to subjects in need, particularly those suffering from bacterial infections. Additionally, the composition can be applied to surfaces to eliminate or reduce bacteria.
Career Highlights
Ulyana is affiliated with The Ohio State University, where she continues her research and development in antimicrobial solutions. Her work is crucial in the ongoing battle against antibiotic resistance and the need for effective antimicrobial agents.
Collaborations
Ulyana collaborates with esteemed colleagues such as Gireesh Rajashekara and Janet Antwi, contributing to a dynamic research environment focused on innovative solutions in health and medicine.
Conclusion
Ulyana Munoz Acuna's contributions to antimicrobial research exemplify the importance of innovation in addressing public health challenges. Her work not only advances scientific knowledge but also has the potential to improve treatment options for bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
